Uterine Fibroid Treatment Drugs Market Size, Share & Trends Report

Uterine Fibroid Treatment Drugs Market Size, Share & Trends Analysis Report By Drug Class (GnRH Agonists, GnRH Antagonists), By Type (Submucosal Fibroids, Intramural Fibroids), By End-user, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-065-3
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Uterine Fibroid Treatment Drugs Type Outlook (Revenue, USD Million, 2018 - 2030)
- Subserosal Fibroids
- Intramural Fibroids
- Submucosal Fibroids
- Pedunculated Fibroids
Uterine Fibroid Treatment Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Gonadotropin-releasing Hormone (GnRH) Agonists
- Gonadotropin-releasing Hormone (GnRH) Antagonists
- Progestin-releasing Intrauterine Device (IUD) & Contraceptives
- Non-hormonal Medications
- Others
Uterine Fibroid Treatment Drugs End-User Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Uterine Fibroid Treatment Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Uterine Fibroid Treatment Drugs Market, By Drug Class
    - Gonadotropin-releasing Hormone (GnRH) Agonists
    - Gonadotropin-releasing Hormone (GnRH) Antagonists
    - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
    - Non-hormonal Medications
    - Others
  - North America Uterine Fibroid Treatment Drugs Market, By Type
    - Subserosal Fibroids
    - Intramural Fibroids
    - Submucosal Fibroids
    - Pedunculated Fibroids
  - North America Uterine Fibroid Treatment Drugs Market, By End-User
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - U.S.
    - U.S. Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - U.S. Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - U.S. Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Canada
    - Canada Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Canada Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Canada Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Europe
  - Europe Uterine Fibroid Treatment Drugs Market, By Drug Class
    - Gonadotropin-releasing Hormone (GnRH) Agonists
    - Gonadotropin-releasing Hormone (GnRH) Antagonists
    - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
    - Non-hormonal Medications
    - Others
  - Europe Uterine Fibroid Treatment Drugs Market, By Type
    - Subserosal Fibroids
    - Intramural Fibroids
    - Submucosal Fibroids
    - Pedunculated Fibroids
  - Europe Uterine Fibroid Treatment Drugs Market, By End-User
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - UK
    - UK Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - UK Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - UK Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Germany
    - Germany Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Germany Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Germany Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - France
    - France Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - France Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - France Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Italy
    - Italy Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Italy Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Italy Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Spain
    - Spain Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Spain Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Spain Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Denmark
    - Denmark Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Denmark Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Denmark Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Sweden
    - Sweden Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Sweden Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Sweden Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Norway
    - Norway Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Norway Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Norway Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Asia Pacific
- Latin America
  - Latin America Uterine Fibroid Treatment Drugs Market, By Drug Class
    - Gonadotropin-releasing Hormone (GnRH) Agonists
    - Gonadotropin-releasing Hormone (GnRH) Antagonists
    - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
    - Non-hormonal Medications
    - Others
  - Latin America Uterine Fibroid Treatment Drugs Market, By Type
    - Subserosal Fibroids
    - Intramural Fibroids
    - Submucosal Fibroids
    - Pedunculated Fibroids
  - Latin America Uterine Fibroid Treatment Drugs Market, By End-User
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Brazil
    - Brazil Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Brazil Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Brazil Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Mexico
    - Mexico Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Mexico Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Mexico Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Argentina
    - Argentina Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Argentina Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Argentina Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- MEA
  - MEA Uterine Fibroid Treatment Drugs Market, By Drug Class
    - Gonadotropin-releasing Hormone (GnRH) Agonists
    - Gonadotropin-releasing Hormone (GnRH) Antagonists
    - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
    - Non-hormonal Medications
    - Others
  - MEA Uterine Fibroid Treatment Drugs Market, By Type
    - Subserosal Fibroids
    - Intramural Fibroids
    - Submucosal Fibroids
    - Pedunculated Fibroids
  - MEA Uterine Fibroid Treatment Drugs Market, By End-User
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - South Africa
    - South Africa Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - South Africa Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - South Africa Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Saudi Arabia
    - Saudi Arabia Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Saudi Arabia Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Saudi Arabia Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - UAE
    - UAE Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - UAE Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - UAE Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Kuwait
    - Kuwait Uterine Fibroid Treatment Drugs Market, By Drug Class
      - Gonadotropin-releasing Hormone (GnRH) Agonists
      - Gonadotropin-releasing Hormone (GnRH) Antagonists
      - Progestin-releasing Intrauterine Device (IUD) & Contraceptives
      - Non-hormonal Medications
      - Others
    - Kuwait Uterine Fibroid Treatment Drugs Market, By Type
      - Subserosal Fibroids
      - Intramural Fibroids
      - Submucosal Fibroids
      - Pedunculated Fibroids
    - Kuwait Uterine Fibroid Treatment Drugs Market, By End-User
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.